Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis

IF 5.3 2区 医学 Q1 CLINICAL NEUROLOGY
Simon Reiche , Tim Hirschfeld , Anna Lena Gröticke , Marie Traub , Nicklas Jakob Hafiz , Rico Haas , Lara Sedlaczek , Linda Ortlieb , Georg Leistenschneider , Lukas A. Basedow , Andrea Lohse , Felix Bermpohl , Thomas Günther Riemer , Tomislav Majić
{"title":"Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis","authors":"Simon Reiche ,&nbsp;Tim Hirschfeld ,&nbsp;Anna Lena Gröticke ,&nbsp;Marie Traub ,&nbsp;Nicklas Jakob Hafiz ,&nbsp;Rico Haas ,&nbsp;Lara Sedlaczek ,&nbsp;Linda Ortlieb ,&nbsp;Georg Leistenschneider ,&nbsp;Lukas A. Basedow ,&nbsp;Andrea Lohse ,&nbsp;Felix Bermpohl ,&nbsp;Thomas Günther Riemer ,&nbsp;Tomislav Majić","doi":"10.1016/j.pnpbp.2025.111353","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Evidence on the neuropsychological consequences of classic psychedelics like psilocybin, LSD, and ayahuasca is conflicting, and little is known about how sporadic use of psychedelics under naturalistic conditions may affect cognitive functioning. Given the growing interest in the therapeutic potential of psychedelics and the rise in non-medical use, further exploration into their neuropsychological effects is needed.</div></div><div><h3>Methods</h3><div>This cross-sectional, exploratory study employed a comprehensive neuropsychological test battery to assess cognitive domains such as executive function, memory, attention, and visuospatial abilities among individuals with mild to moderate lifetime use of psychedelics. Analyses compared all users to non-users, moderate users to matched controls, and adjusted dose-response analyses were conducted within the users group.</div></div><div><h3>Results</h3><div>From 2611 screened individuals, <em>N</em> = 136 participants (84 psychedelic users and 52 controls) were included. Participants were aged 18–50 years. Neuropsychological performance was broadly equivalent between users and controls. However, matched-pair analyses showed that psychedelic users had a modest advantage in executive functions, especially superior performance on the Wisconsin Card Sorting Test (WCST) (<em>p</em> &lt; .05). Dose-response analyses further corroborated these findings, indicating a positive association between lifetime psychedelic use and performance on the WCST, specifically total errors (<em>p</em> &lt; .001), perseverative responses (<em>p</em> &lt; .001), perseverative errors (<em>p</em> &lt; .001), non-perseverative errors (<em>p</em> = .008), and conceptual level responses (<em>p</em> = .004).</div></div><div><h3>Conclusions</h3><div>The study did not detect any negative associations between sporadic lifetime psychedelic use and cognition. Instead, a moderate association with executive functioning was found, indicating increased cognitive flexibility in users. Dose-response analyses further supported this relationship.</div></div>","PeriodicalId":54549,"journal":{"name":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","volume":"138 ","pages":"Article 111353"},"PeriodicalIF":5.3000,"publicationDate":"2025-04-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Progress in Neuro-Psychopharmacology & Biological Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0278584625001071","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Evidence on the neuropsychological consequences of classic psychedelics like psilocybin, LSD, and ayahuasca is conflicting, and little is known about how sporadic use of psychedelics under naturalistic conditions may affect cognitive functioning. Given the growing interest in the therapeutic potential of psychedelics and the rise in non-medical use, further exploration into their neuropsychological effects is needed.

Methods

This cross-sectional, exploratory study employed a comprehensive neuropsychological test battery to assess cognitive domains such as executive function, memory, attention, and visuospatial abilities among individuals with mild to moderate lifetime use of psychedelics. Analyses compared all users to non-users, moderate users to matched controls, and adjusted dose-response analyses were conducted within the users group.

Results

From 2611 screened individuals, N = 136 participants (84 psychedelic users and 52 controls) were included. Participants were aged 18–50 years. Neuropsychological performance was broadly equivalent between users and controls. However, matched-pair analyses showed that psychedelic users had a modest advantage in executive functions, especially superior performance on the Wisconsin Card Sorting Test (WCST) (p < .05). Dose-response analyses further corroborated these findings, indicating a positive association between lifetime psychedelic use and performance on the WCST, specifically total errors (p < .001), perseverative responses (p < .001), perseverative errors (p < .001), non-perseverative errors (p = .008), and conceptual level responses (p = .004).

Conclusions

The study did not detect any negative associations between sporadic lifetime psychedelic use and cognition. Instead, a moderate association with executive functioning was found, indicating increased cognitive flexibility in users. Dose-response analyses further supported this relationship.
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
12.00
自引率
1.80%
发文量
153
审稿时长
56 days
期刊介绍: Progress in Neuro-Psychopharmacology & Biological Psychiatry is an international and multidisciplinary journal which aims to ensure the rapid publication of authoritative reviews and research papers dealing with experimental and clinical aspects of neuro-psychopharmacology and biological psychiatry. Issues of the journal are regularly devoted wholly in or in part to a topical subject. Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信